Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03287687 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of CO2 for Endoscopy
A Phase 4 study, sponsored by Warren Bishop.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT03287687 is a Phase 4 study that has completed, run by Warren Bishop. The registered enrollment target is 180 participants.
The verdict
NCT03287687, a Phase 4 study, has completed, sponsored by Warren Bishop.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
Hypothesis: Carbon dioxide gas use for endoscopic insufflation is safe and results in less abdominal distension and discomfort; it is equally effective as air in pediatric patients undergoing endoscopic procedures. Aim 1: Determine the occurrence and severity of abdominal discomfort and distension associated with endoscopic procedures at baseline, upon awakening from anesthesia, at discharge and at 4 hours after discharge in carbon dioxide group when compared to the air group. Aim 2: Determine if the expertise level of the endoscopist contributes to abdominal discomfort and distension following endoscopy, and whether this differs in the carbon dioxide group versus air group. Aim 3: Determine if carbon dioxide is as effective as air for insufflation.
Interventions
- DRUG Carbon dioxide (CO2) gas insufflation
- DRUG Air insufflation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2019-04-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03287687
The ClinicalTrials.gov registry entry for NCT03287687 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warren Bishop, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carbon dioxide (CO2) gas insufflation is the first listed.
NCT03287687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03287687 about?
NCT03287687 is a clinical study titled "Safety and Efficacy of CO2 for Endoscopy". Hypothesis: Carbon dioxide gas use for endoscopic insufflation is safe and results in less abdominal distension and discomfort; it is equally effective as air in pediatric patients undergoing endoscopic procedures. Aim 1: Determine the occurrence and severity of abdominal discomfort and distensio...
What is the current status of trial NCT03287687?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2017-11-27. Estimated completion is 2019-04-09.
What interventions are being tested in trial NCT03287687?
The interventions under investigation include: Carbon dioxide (CO2) gas insufflation (DRUG), Air insufflation (DRUG).
Who is sponsoring clinical trial NCT03287687?
This trial is sponsored by Warren Bishop, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.